Literature DB >> 14500990

Polymorphism of angiotensin-converting enzyme, angiotensinogen, and apolipoprotein E genes in Korean patients with cerebral infarction.

Jae-Young Um1, Kyung-Suk Moon, Kang-Min Lee, Kwang-Ho Cho, Yun Heo, Byung-Soon Moon, Hyung-Min Kim.   

Abstract

The homozygous deletion allele of the angiotensin-converting enzyme gene (ACE/DD), homozygous threonine allele of the angiotensinogen gene (AGN/TT), and the epsilon4 allele of the apolipoprotein E gene (apoE/epsilon4) are reported to be associated with ischemic heart disease. Cerebral infarction (CI) is another atherosclerotic disease, and the effects of these polymorphisms on CI have been confusing. The frequency of the DD genotype of the ACE gene, but not the TT genotype of the AGN gene and the epsilon4 allele of ApoE, was significantly higher in subjects with than those without CI in Japan. In this study, we investigated whether ACE/DD, AGN/TT, and apoE/epsilon4 genotypes are associated with CI and whether genetic risk is enhanced by the effect of one upon another. We ascertained these genotypes in patients with CI (n = 365), diagnosed by brain computed tomography. Control subjects for the infarction group were randomly selected from 319 subjects matched for age, gender, and history of hypertension with patients. The ACE/DD genotype was not associated with CI. Frequency of the AGN/TT genotype was higher in patients with CI than in controls (chi2 = 12.287, p < 0.05). The frequency of t allele was 0.88 in patients and 0.82 in controls (chi2 = 11.041, p < 0.05; odds ratio, 1.7). Furthermore, the AGN/TT genotype increased the relative risk for CI in subjects with the ACE/DD genotype (chi2 = 7.8, p < 0.05; odds ratio, 1.9). There was no significant association between apoE/epsilon4 and CI. These results suggest that AGN/TT predicts CI and ACE/DD enhances the risk for CI associated with AGN/TT in a Korean population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14500990     DOI: 10.1385/JMN:21:1:23

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

1.  A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction.

Authors:  N J Samani; J R Thompson; L O'Toole; K Channer; K L Woods
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction.

Authors:  A Batalla; R Alvarez; J R Reguero; S Hevia; G Iglesias-Cubero; V Alvarez; A Cortina; P González; M M Celada; A Medina; E Coto
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

4.  Apolipoprotein E variants in ischemic stroke.

Authors:  F Coria; I Rubio; E Nuñez; A P Sempere; N SantaEngarcia; C Bayón; N Cuadrado
Journal:  Stroke       Date:  1995-12       Impact factor: 7.914

5.  Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population.

Authors:  M J MacLeod; R P De Lange; G Breen; D Meiklejohn; H Lemmon; D S Clair
Journal:  Eur J Clin Invest       Date:  2001-07       Impact factor: 4.686

6.  M235T angiotensinogen gene polymorphism and cardiovascular renal risk.

Authors:  J A Staessen; T Kuznetsova; J G Wang; D Emelianov; R Vlietinck; R Fagard
Journal:  J Hypertens       Date:  1999-01       Impact factor: 4.844

7.  Lack of association between angiotensinogen polymorphism (M235T) and cerebrovascular disease and carotid atheroma.

Authors:  J Barley; H Markus; M Brown; N Carter
Journal:  J Hum Hypertens       Date:  1995-08       Impact factor: 3.012

Review 8.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

9.  Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.

Authors:  S Lehtinen; T Lehtimäki; T Sisto; J P Salenius; M Nikkilä; H Jokela; T Koivula; F Ebeling; C Ehnholm
Journal:  Atherosclerosis       Date:  1995-04-07       Impact factor: 5.162

10.  Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism.

Authors:  A H Danser; M A Schalekamp; W A Bax; A M van den Brink; P R Saxena; G A Riegger; H Schunkert
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

View more
  9 in total

1.  Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology.

Authors:  M J E van Rijn; M J Bos; A Isaacs; M Yazdanpanah; A Arias-Vásquez; B H Ch Stricker; O H Klungel; B A Oostra; P J Koudstaal; J C Witteman; A Hofman; M M B Breteler; C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-12       Impact factor: 10.154

Review 2.  Association between Apolipoprotein ε4 Gene Polymorphism and Risk of Ischemic Stroke: A Meta-Analysis.

Authors:  Amit Kumar; Pradeep Kumar; Manya Prasad; Shubham Misra; Awadh Kishor Pandit; Kamalesh Chakravarty
Journal:  Ann Neurosci       Date:  2016-07-07

3.  TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction.

Authors:  Jae-Young Um; Neeon-Hyung An; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

4.  Interaction of angiotensin-converting enzyme and apolipoprotein E gene polymorphisms in ischemic stroke involving large-vessel disease.

Authors:  Sarra Saidi; Walid Zammiti; Lamia B Slamia; Sofyan B Ammou; Wassim Y Almawi; Touhami Mahjoub
Journal:  J Thromb Thrombolysis       Date:  2007-11-21       Impact factor: 2.300

5.  Angiotensin II type-1 receptor A1166C polymorphism is associated with increased risk of ischemic stroke in hypertensive smokers.

Authors:  Zoltán Szolnoki; Viktória Havasi; Gábor Talián; Judit Bene; Katalin Komlósi; Ferenc Somogyvári; András Kondacs; Mihály Szabó; Lajos Fodor; Anita Bodor; Béla Melegh
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

6.  Assessment of two missense polymorphisms (rs4762 and rs699) of the angiotensinogen gene and stroke.

Authors:  Hyun-Kyung Park; Myung-Chun Kim; Sung-Min Kim; Dae Jean Jo
Journal:  Exp Ther Med       Date:  2012-01-11       Impact factor: 2.447

7.  Genetics of ischaemic stroke among persons of non-European descent: a meta-analysis of eight genes involving approximately 32,500 individuals.

Authors:  Roshan Ariyaratnam; Juan P Casas; John Whittaker; Liam Smeeth; Aroon D Hingorani; Pankaj Sharma
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

8.  Angiotensinogen gene polymorphism and ischemic stroke in East Asians: A meta-analysis.

Authors:  Sheng Wang; Rong Zeng; Limin Lei; Jinsong Huang
Journal:  Neural Regen Res       Date:  2013-05-05       Impact factor: 5.135

9.  Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke.

Authors:  Sanja Stankovic; Aleksandra Stankovic; Milika Asanin; Zagorka Jovanovic-Markovic; Dragan Alavantic; Nada Majkic-Singh
Journal:  EJIFCC       Date:  2011-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.